NVNO (enVVeno Medical) Cyclically Adjusted PB Ratio: (As of Jul. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVNO enVVeno Medical Corp NVNO
26 GF Score
Price $10.67
! 3 Warning Signs
View Full Analysis

What is enVVeno Medical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


enVVeno Medical  (NAS:NVNO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


enVVeno Medical Cyclically Adjusted PB Ratio Related Terms


enVVeno Medical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for enVVeno Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

enVVeno Medical Cyclically Adjusted PB Ratio Chart

enVVeno Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

enVVeno Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NVNO vs CODX, HSCS, AIDX: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, enVVeno Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


enVVeno Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where enVVeno Medical's Cyclically Adjusted PB Ratio falls into.


NVNO
26GF Score
enVVeno Medical Corp NVNO
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

enVVeno Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

enVVeno Medical's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, enVVeno Medical's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=36.2/330.2130*330.2130
=36.200

Current CPI (Mar. 2026) = 330.2130.

enVVeno Medical Quarterly Data

Book Value per Share CPI Adj_Book
201512 -325.182 236.525 -453.987
201609 0.000 241.428 0.000
201612 -383.545 241.432 -524.585
201703 0.000 243.801 0.000
201706 -577.909 244.955 -779.054
201709 -741.909 246.819 -992.582
201712 -1,011.909 246.524 -1,355.428
201803 -1,311.750 249.554 -1,735.724
201806 354.692 251.989 464.798
201809 272.462 252.439 356.405
201812 156.615 251.233 205.850
201903 179.063 254.202 232.606
201906 232.600 256.143 299.862
201909 154.200 256.759 198.314
201912 49.500 256.974 63.608
202003 -0.682 258.115 -0.872
202006 13.667 257.797 17.506
202009 104.239 260.280 132.246
202012 97.233 260.474 123.266
202103 177.004 264.877 220.665
202106 168.206 271.696 204.434
202109 214.221 274.310 257.878
202112 200.753 278.802 237.772
202203 189.362 287.504 217.492
202206 171.801 296.311 191.457
202209 157.458 296.808 175.180
202212 142.911 296.797 159.001
202303 125.937 301.836 137.777
202306 106.317 305.109 115.065
202309 91.937 307.789 98.635
202312 121.579 306.746 130.880
202403 111.205 312.332 117.571
202406 100.835 314.175 105.982
202409 94.551 315.301 99.023
202412 84.150 315.605 88.045
202503 76.461 319.799 78.951
202506 60.104 322.561 61.530
202509 50.946 324.800 51.795
202512 41.357 324.054 42.143
202603 36.200 330.213 36.200

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


enVVeno Medical Business Description

Address 70 Doppler, Irvine, CA, USA, 92618
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score

Get the complete analysis for NVNO

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.67
Price